Pharmaceutical & Life Sciences News

China Opens a ‘Pandora’s Box’ of Genetic Engineering (2)

Nov. 27, 2018, 2:00 PMUpdated: Nov. 27, 2018, 1:50 PM

A Chinese researcher’s claim that he successfully modified the genes of human embryos may force the country to make a stark choice about the future of its burgeoning biotechnology industry — one with significant implications for an emerging technology arms race with the West.

He Jiankui, an American-educated scientist based in Shenzhen, announced on Nov. 26 that he’d used Crispr, a powerful gene-editing tool, to make recently born twin girls resistant to HIV. He’s statement, which was not backed by peer-reviewed data and hasn’t been verified, prompted widespread condemnation from scientists in China and elsewhere, with many calling it an...

To read the full article log in. To learn more about a subscription click here.